• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用混合系统对药物效应进行动态建模。

Dynamical modeling of drug effect using hybrid systems.

作者信息

Li Xiangfang, Qian Lijun, Dougherty Edward R

机构信息

Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX 77843, USA.

出版信息

EURASIP J Bioinform Syst Biol. 2012 Dec 26;2012(1):19. doi: 10.1186/1687-4153-2012-19.

DOI:10.1186/1687-4153-2012-19
PMID:23268741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3639233/
Abstract

: Drug discovery today is a complex, expensive, and time-consuming process with high attrition rate. A more systematic approach is needed to combine innovative approaches in order to lead to more effective and efficient drug development. This article provides systematic mathematical analysis and dynamical modeling of drug effect under gene regulatory network contexts. A hybrid systems model, which merges together discrete and continuous dynamics into a single dynamical model, is proposed to study dynamics of the underlying regulatory network under drug perturbations. The major goal is to understand how the system changes when perturbed by drugs and give suggestions for better therapeutic interventions. A realistic periodic drug intake scenario is considered, drug pharmacokinetics and pharmacodynamics information being taken into account in the proposed hybrid systems model. Simulations are performed using MATLAB/SIMULINK to corroborate the analytical results.

摘要

当今的药物发现是一个复杂、昂贵且耗时的过程,淘汰率很高。需要一种更系统的方法来结合创新方法,以实现更有效和高效的药物开发。本文提供了在基因调控网络背景下药物效应的系统数学分析和动态建模。提出了一种混合系统模型,该模型将离散和连续动力学合并到一个单一的动力学模型中,以研究药物扰动下潜在调控网络的动力学。主要目标是了解系统在受到药物扰动时如何变化,并为更好的治疗干预提供建议。考虑了一种现实的周期性药物摄入情况,在所提出的混合系统模型中纳入了药物的药代动力学和药效学信息。使用MATLAB/SIMULINK进行仿真以证实分析结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/88eae3bf5cc9/1687-4153-2012-19-20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/25e3d167e4ef/1687-4153-2012-19-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/67be680798d0/1687-4153-2012-19-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/2bc404dfa3b2/1687-4153-2012-19-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/0588372740ad/1687-4153-2012-19-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/1c8630b23b4b/1687-4153-2012-19-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/868cd38d8881/1687-4153-2012-19-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/3a584e35f9e1/1687-4153-2012-19-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/2556d2c2b6f2/1687-4153-2012-19-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/622f4fb8456c/1687-4153-2012-19-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/9d25bee2c5db/1687-4153-2012-19-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/62177f75712b/1687-4153-2012-19-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/d74cd68d81e4/1687-4153-2012-19-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/61841d14ca23/1687-4153-2012-19-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/5d6ad05ea0b5/1687-4153-2012-19-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/54273db4b068/1687-4153-2012-19-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/5fc2d932ff9d/1687-4153-2012-19-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/f01eaf304403/1687-4153-2012-19-17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/a6744298ef9d/1687-4153-2012-19-18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/ed6e02cf1fbd/1687-4153-2012-19-19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/88eae3bf5cc9/1687-4153-2012-19-20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/25e3d167e4ef/1687-4153-2012-19-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/67be680798d0/1687-4153-2012-19-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/2bc404dfa3b2/1687-4153-2012-19-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/0588372740ad/1687-4153-2012-19-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/1c8630b23b4b/1687-4153-2012-19-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/868cd38d8881/1687-4153-2012-19-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/3a584e35f9e1/1687-4153-2012-19-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/2556d2c2b6f2/1687-4153-2012-19-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/622f4fb8456c/1687-4153-2012-19-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/9d25bee2c5db/1687-4153-2012-19-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/62177f75712b/1687-4153-2012-19-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/d74cd68d81e4/1687-4153-2012-19-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/61841d14ca23/1687-4153-2012-19-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/5d6ad05ea0b5/1687-4153-2012-19-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/54273db4b068/1687-4153-2012-19-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/5fc2d932ff9d/1687-4153-2012-19-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/f01eaf304403/1687-4153-2012-19-17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/a6744298ef9d/1687-4153-2012-19-18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/ed6e02cf1fbd/1687-4153-2012-19-19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/3639233/88eae3bf5cc9/1687-4153-2012-19-20.jpg

相似文献

1
Dynamical modeling of drug effect using hybrid systems.使用混合系统对药物效应进行动态建模。
EURASIP J Bioinform Syst Biol. 2012 Dec 26;2012(1):19. doi: 10.1186/1687-4153-2012-19.
2
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
3
A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens-a Modeling Study of Drug Effects on Tumor Growth using Hybrid Systems.一种用于不同给药方案治疗反应研究的系统生物学方法——使用混合系统对药物对肿瘤生长影响的建模研究
Cancer Inform. 2012;11:41-60. doi: 10.4137/CIN.S8185. Epub 2012 Feb 27.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
[Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].[精神病理学中的动态范式:“混沌理论”,从物理学到精神病学]
Encephale. 2001 May-Jun;27(3):260-8.
7
Theory of hybrid dynamical systems and its applications to biological and medical systems.混合动态系统理论及其在生物和医学系统中的应用。
Philos Trans A Math Phys Eng Sci. 2010 Nov 13;368(1930):4893-914. doi: 10.1098/rsta.2010.0237.
8
Hybrid modeling frameworks of tumor development and treatment.肿瘤发展和治疗的混合建模框架。
Wiley Interdiscip Rev Syst Biol Med. 2020 Jan;12(1):e1461. doi: 10.1002/wsbm.1461. Epub 2019 Jul 17.
9
A perturbative approach to study information communication in brain networks.一种用于研究脑网络中信息通信的微扰方法。
Netw Neurosci. 2022 Oct 1;6(4):1275-1295. doi: 10.1162/netn_a_00260. eCollection 2022.
10
Characterization of drug efficacy regions based on dosage and frequency schedules.基于剂量和用药频率的药效区域特征描述。
IEEE Trans Biomed Eng. 2011 Mar;58(3):488-98. doi: 10.1109/TBME.2010.2090660. Epub 2010 Nov 9.

引用本文的文献

1
Multiscale Tumor Modeling With Drug Pharmacokinetic and Pharmacodynamic Profile Using Stochastic Hybrid System.使用随机混合系统的具有药物药代动力学和药效学特征的多尺度肿瘤建模
Cancer Inform. 2018 Jul 27;17:1176935118790262. doi: 10.1177/1176935118790262. eCollection 2018.
2
Time-Based Switching Control of Genetic Regulatory Networks: Toward Sequential Drug Intake for Cancer Therapy.基因调控网络的基于时间的切换控制:迈向癌症治疗的序贯药物摄入
Cancer Inform. 2017 May 10;16:1176935117706888. doi: 10.1177/1176935117706888. eCollection 2017.
3
Integrating Multiscale Modeling with Drug Effects for Cancer Treatment.

本文引用的文献

1
Assessing the efficacy of molecularly targeted agents on cell line-based platforms by using system identification.基于系统辨识评估基于细胞系的平台上分子靶向药物的疗效。
BMC Genomics. 2012;13 Suppl 6(Suppl 6):S11. doi: 10.1186/1471-2164-13-S6-S11. Epub 2012 Oct 26.
2
Characterization of drug efficacy regions based on dosage and frequency schedules.基于剂量和用药频率的药效区域特征描述。
IEEE Trans Biomed Eng. 2011 Mar;58(3):488-98. doi: 10.1109/TBME.2010.2090660. Epub 2010 Nov 9.
3
Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.
将多尺度建模与药物效应整合用于癌症治疗。
Cancer Inform. 2016 Jan 13;14(Suppl 5):21-31. doi: 10.4137/CIN.S30797. eCollection 2015.
HER2-HER3 致癌驱动因素中的弹性和脆弱性。
Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389.
4
Conditioning-based modeling of contextual genomic regulation.
IEEE/ACM Trans Comput Biol Bioinform. 2009 Apr-Jun;6(2):310-20. doi: 10.1109/TCBB.2007.70247.
5
Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.核因子-κB是癌症治疗的理想靶点吗?希望与困境。
Nat Rev Drug Discov. 2009 Jan;8(1):33-40. doi: 10.1038/nrd2781.
6
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.短暂有效的BCR-ABL抑制足以使慢性髓性白血病细胞不可逆地走向凋亡。
Cancer Cell. 2008 Dec 9;14(6):485-93. doi: 10.1016/j.ccr.2008.11.001.
7
Quantitative approaches to the study of bistability in the lac operon of Escherichia coli.大肠杆菌乳糖操纵子双稳性研究的定量方法。
J R Soc Interface. 2008 Aug 6;5 Suppl 1(Suppl 1):S29-39. doi: 10.1098/rsif.2008.0086.focus.
8
Proteasome inhibitors in cancer therapy: lessons from the first decade.癌症治疗中的蛋白酶体抑制剂:首个十年的经验教训
Clin Cancer Res. 2008 Mar 15;14(6):1649-57. doi: 10.1158/1078-0432.CCR-07-2218.
9
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.发现毒理学和病理学在更安全的药物先导化合物设计中的应用。
Nat Rev Drug Discov. 2007 Aug;6(8):636-49. doi: 10.1038/nrd2378.
10
Analysis of lactose metabolism in E. Coli using reachability analysis of hybrid systems.使用混合系统可达性分析对大肠杆菌乳糖代谢进行分析。
IET Syst Biol. 2007 Mar;1(2):130-48. doi: 10.1049/iet-syb:20060035.